| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/05/2008 | CA2163989C Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 07/31/2008 | WO2008092117A2 Immunoglobulins with modifications in the fcr binding region |
| 07/31/2008 | WO2008092019A1 Fgf-23 polypeptides |
| 07/31/2008 | WO2008091954A2 Optimized cd40 antibodies and methods of using the same |
| 07/31/2008 | WO2008091798A2 Optimized ca9 antibodies and methods of using the same |
| 07/31/2008 | WO2008091740A2 Polyelectrolyte precipitation and purification of antibodies |
| 07/31/2008 | WO2008091657A1 Flu vaccines and methods of use thereof |
| 07/31/2008 | WO2008091535A2 Antibodies to phosphorylated-irak4 |
| 07/31/2008 | WO2008091222A1 Dll4 signaling inhibitors and uses thereof |
| 07/31/2008 | WO2008090960A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| 07/31/2008 | WO2008090959A1 Genetically recombinant antibody composition having enhanced effector activity |
| 07/31/2008 | WO2008090958A1 Domain-exchanged recombinant antibody composition |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090319A2 Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| 07/31/2008 | WO2008090222A1 Method for increasing protein yields |
| 07/31/2008 | WO2008090177A2 Diagnosis of prostate cancer |
| 07/31/2008 | WO2008089795A1 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 07/31/2008 | WO2008089567A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089566A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008068359A3 Method for producing antibodies by immunisation with haptens bound to metal oxide particles |
| 07/31/2008 | WO2008067651B1 Gender selection with the use of antibodies |
| 07/31/2008 | WO2008067084A3 Methods for reducing phosphate absorption |
| 07/31/2008 | WO2008051797A3 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 07/31/2008 | WO2008042236A3 Compositions and methods for diagnosing and treating cancer |
| 07/31/2008 | WO2008031061A3 Anti-activin a antibodies and uses thereof |
| 07/31/2008 | WO2008019199A3 FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 07/31/2008 | WO2007149067A3 Methods of using phhla2 to co-stimulate t-cells |
| 07/31/2008 | WO2007111965A3 Hepatitis c virus neutralizing antibodies |
| 07/31/2008 | WO2007085815A8 Ligands that bind il-4 and/or il-13 |
| 07/31/2008 | WO2005019407A3 Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases |
| 07/31/2008 | US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein |
| 07/31/2008 | US20080182978 administering antibodies against nerve growth factors, comprising heavy chain and light chain peptides, treatment and/or prevention of post-surgical, rheumatoid arthritis and osteoarthritic pain |
| 07/31/2008 | US20080182977 Molecules associated with cell proliferation |
| 07/31/2008 | US20080182976 kit for detecting erythropoietin receptors which is capable of being activated comprising an antibody or fragment which activates formation or production of erythrocytes; treatment of anemia |
| 07/31/2008 | US20080182975 Framework-Patched Immunoglobulins |
| 07/31/2008 | US20080182793 Polypeptide comprising oxidized lipid and/or carbohydrate binding activity for use as tool in diagnosis, prevention and treatment of thrombosis, atherosclerosis, inflammatory and bone disorders |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182782 Truncated cytochrome c551 for use as therapeutic agents in prevention and treatment of viral infection and cell proliferative dsorders |
| 07/31/2008 | US20080182332 Optimized non-canonical zinc finger proteins |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182315 specified domain capable of independently functioning as a potential sensor and another domain exhibiting a phosphatise activity; capable of converting electrical signals to chemical signals |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182299 Polynucleotide variants of brain natriuretic peptides used as diagnostic markers for cardiovascular diseases including myocardial infarct, acute coronary syndrome, angina pectoris (stable and unstable), cardiomyopathy, myocarditis, congestive heart failure; kits; monitoring disease progression , relapse |
| 07/31/2008 | US20080182296 Pcr-directed gene synthesis from large number of overlapping oligodeoxyribonucleotides |
| 07/31/2008 | US20080182294 Recombinant clostridial neurotoxins (botulinum) having functional binding, translocation, and therapeutic domains; also an amino acid sequence susceptible to specific cleavage by proteases in vitro following expression as a single chain; inserts; therapeutic agents, transporter molecules; drug delivery |
| 07/31/2008 | US20080182284 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
| 07/31/2008 | US20080182281 detection sensitivity comparable to that in a conventional determination method, easy to handle a sample after collection, and highly reproducible measurements; diagnoses, monitoring of the treatment, monitoring of recurrence, or the like of various diseases including small cell lung cancer |
| 07/31/2008 | US20080182275 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/31/2008 | US20080182268 Schizophrenia associated genes, proteins and biallelic markers |
| 07/31/2008 | US20080182267 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 07/31/2008 | US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/31/2008 | US20080182236 Within human chromosome 7p15-p14; GPRA polypeptides, nucleic acids, host cells, primers and probes; transgenic animal models; anticarcinogenic agents; chronic obstructive pulmonary disorder; diagnosis; analyzing allelic variation in the locus and GPRA gene |
| 07/31/2008 | US20080182233 Methods and compositions for depleting specific cell populations from blood tissues |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181916 Contains inactive strains of Borrelia genospecies; serums; antibodies |
| 07/31/2008 | US20080181915 Cd40 ligand adjuvant for respiratory syncytial virus |
| 07/31/2008 | US20080181908 Genes and proteins, and their use |
| 07/31/2008 | US20080181907 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
| 07/31/2008 | US20080181904 Contains collagen-like domain and Clq domain; idiotypic antibodies; humanizing; biosynthesis |
| 07/31/2008 | US20080181903 Urodilatin; immunoglobulins; fusion proteins; pharmacokinetics |
| 07/31/2008 | US20080181902 Mutant protofibril for active immunisation; synuclein genes, proteins; Parkinson's disease; dementia |
| 07/31/2008 | US20080181901 Protein modulator of the plasma membrane Na,K-ATPase |
| 07/31/2008 | US20080181900 Vascular Endothelial Cell Growth Factor Antagonists |
| 07/31/2008 | US20080181899 Blocks binding to Notch receptor; surface plasmon resonance |
| 07/31/2008 | US20080181898 Wise/sost nucleic acid sequences and amino acid sequences |
| 07/31/2008 | US20080181897 Which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation |
| 07/31/2008 | US20080181895 SP16 protein |
| 07/31/2008 | US20080181892 Binding Domain Fusion Protein |
| 07/31/2008 | US20080181891 Modified human igf-ir antibodies |
| 07/31/2008 | US20080181890 antibody or immunoadhesin increases binding affinity to an Fc variants; amino acid substitution; glycosylated Fc; computer aided drug design; drug target |
| 07/31/2008 | US20080181889 antagonist of epithelial membrane protein-2, blocking the entry of Chlamydia into the host cell; biodrug for treating gramnegative bacteria intracellular prokaryotic pathogens; drug screening |
| 07/31/2008 | US20080181888 Polypeptides That Bind Br3 and Uses Thereof |
| 07/31/2008 | US20080181886 Polypeptides That Bind Baff And/Or April |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |
| 07/31/2008 | US20080181883 Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same |
| 07/31/2008 | CA2676529A1 Genetically recombinant antibody composition having enhanced effector activity |
| 07/31/2008 | CA2676436A1 Diagnosis of prostate cancer |
| 07/31/2008 | CA2676244A1 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease |
| 07/31/2008 | CA2676234A1 Use of antibody conjugates |
| 07/31/2008 | CA2676091A1 Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| 07/31/2008 | CA2676008A1 Compositions and methods for diagnosing and treating cancer |
| 07/31/2008 | CA2675293A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2675292A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2674897A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2673851A1 Polyelectrolyte precipitation and purification of proteins |
| 07/31/2008 | CA2669412A1 Optimized cd40 antibodies and methods of using the same |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950299A1 Mammalian receptor proteins; related reagents and methods |
| 07/30/2008 | EP1950292A1 Nato3, MARKER OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 07/30/2008 | EP1950226A2 Receptors for human interleukin-12 |
| 07/30/2008 | EP1950225A1 Method for increasing protein yield |
| 07/30/2008 | EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis |
| 07/30/2008 | EP1949915A2 Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949912A2 Treatment of chronic lymphcytic leukemia (CLL) using chimeric anti-CD20 antibody |
| 07/30/2008 | EP1949911A2 Treatment of chronique lymphocytic leukemia using chimeric anti-CD20 antibody. |
| 07/30/2008 | EP1949910A1 Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody. |
| 07/30/2008 | EP1949109A2 Peptide sequence that promotes tumor invasion |